Identification of genes in ulcerative colitis associated colorectal cancer based on centrality analysis of co-expression network

Neoplasma

Volumn 62, Issue 5, 2015, Pages 756-764

  Zhu, J ^a   Li, C ^a   Ji, W ^a  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

Centrality; Colorectal cancer; Gene; Ulcerative colitis

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; AQUAPORIN 8; CXCL1 CHEMOKINE; MESSENGER RNA; NUCLEOPHOSMIN; SOLUTE CARRIER FAMILY 4;

ADULT; AGED; ARTICLE; CENTRALITY ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DATABASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PATHWAY ENRICHMENT ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR BIOPSY; ULCERATIVE COLITIS;

EID: 84943632997     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2015_090     Document Type: Article

References (46)

1. JESS T, RUNGOE C, Peyrin-Biroulet L, Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol 2012; 10: 639–645. http://dx.doi.org/10.1016/j.cgh.2012.01.010
2. Colitis–Pathophysiology U, Inflammatory bowel disease part I: ulcerative colitis–pathophysiology and conventional and alternative treatment options. Alternative medicine review 2003; 8: 247–283.
3. Rogler G, Chronic ulcerative colitis and colorectal cancer. Cancer letters 2013.
4. KISIEL JB, Garrity-Park MM, TAYLOR WR, SMYRK TC, AHLQUIST DA, Methylated Eyes Absent 4 (EYA4) gene promotor in non-neoplastic mucosa of ulcerative colitis patients with colorectal cancer: evidence for a field effect. Inflammatory bowel diseases 2013; 19: 2079–2083. http://dx.doi.org/10.1097/MIB.0b013e31829b3f4d
5. WATANABE T, KONISHI T, KISHIMOTO J, KOTAKE K, MUTO T, et al., Ulcerative colitis‐associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: A nationwide Japanese study. Inflammatory bowel diseases 2011; 17: 802–808. http://dx.doi.org/10.1002/ibd.21365
6. BARDELLI A, SIENA S, Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer. Journal of Clinical Oncology 2010; 28: 1254–1261. http://dx.doi.org/10.1200/JCO.2009.24.6116
7. SALEH M, TRINCHIERI G, Innate immune mechanisms of colitis and colitis-associated colorectal cancer. Nature Reviews Immunology 2010; 11: 9–20. http://dx.doi.org/10.1038/nri2891
8. SUZUKI H, GABRIELSON E, CHEN W, ANBAZHAGAN R, VAN ENGELAND M, et al., A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nature genetics 2002; 31: 141–149. http://dx.doi.org/10.1038/ng892
9. Sato F, Harpaz N, Shibata D, Xu Y, Yin J, et al., Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis. Cancer Res 2002; 62: 1148–1151.
10. Wang D, Dubois RN, The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 2009; 29: 781–788. http://dx.doi.org/10.1038/onc.2009.421
11. Vinayagam i A, Zirin J, Roesel C, Hu Y, Yilmazel B, et al., Integrating protein-protein interaction networks with phenotypes reveals signs of interactions. Nature methods 2013. http://dx.doi.org/10.1038/nmeth.2733
12. Liangiangiangiang D, Hanan G, Fengengeng X, Sunun J, Duanuanuan Y, et al., Concerted perturbation observed in a hub network in Alzheimer‘s disease. PLoS One 2012; 7: e40498. http://dx.doi.org/10.1371/journal.pone.0040498
13. Montero-Mel Ndez T, Llorl X, Garc A-Planella E, PERRETTI M, and SU REZ A, Identification of Novel Predictor Classifiers for Inflammatory Bowel Disease by Gene Expression Profiling. PloS one 2013; 8: e76235. http://dx.doi.org/10.1371/journal.pone.0076235
14. PLANELL N, LOZANO JJ, Mora-Buch R, Masamunt MC, Jimeno M, et al., Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations. Gut 2013; 62: 967–976. http://dx.doi.org/10.1136/gutjnl-2012-303333
15. WU F, DASSOPOULOS T, COPE L, MAITRA A, BRANT SR, et al., Genome‐wide gene expression differences in Crohn‘s disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflammatory bowel diseases 2007; 13: 807–821. http://dx.doi.org/10.1002/ibd.20110
16. Gyorffy B, Molnar B, Lage H, Szallasi Z, Eklund AC, Evaluation of microarray preprocessing algorithms based on concordance with RT-PCR in clinical samples. PloS one 2009; 4: e5645. http://dx.doi.org/10.1371/journal.pone.0005645
17. SHEFFER M, BACOLOD MD, ZUK O, GIARDINA SF, PINCAS H, et al., Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer. Proceedings of the National Academy of Sciences 2009; 106: 7131–7136. http://dx.doi.org/10.1073/pnas.0902232106
18. ANCONA N, MAGLIETTA R, PIEPOLI A, D‘ADDABBO A, COTUGNO R, et al., On the statistical assessment of classifiers using DNA microarray data. BMC bioinformatics 2006; 7: 387. http://dx.doi.org/10.1186/1471-2105-7-387
19. BOLSTAD B, affy: Built-in Processing Methods. 2013.
20. IRIZARRY RA, BOLSTAD BM, COLLIN F, COPE LM, HOBBS B, et al., Summaries of Affymetrix GeneChip probe level data. Nucleic acids research 2003; 31: e15-e15. http://dx.doi.org/10.1093/nar/gng015
21. BOLSTAD BM, IRIZARRY RA, ASTRAND M, SPEED TP, A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003; 19: 185–193. http://dx.doi.org/10.1093/bioinformatics/19.2.185
22. Liuiu W, Pengengeng Y, Tobinobinobinobin DJ, A new 12-gene diagnostic biomarker signature of melanoma revealed by integrated microarray analysis. PeerJ 2013; 1: e49. http://dx.doi.org/10.7717/peerj.49
23. CHOI JK, YU U, YOO OJ, KIM S, Differential coexpression analysis using microarray data and its application to human cancer. Bioinformatics 2005; 21: 4348–4355. http://dx.doi.org/10.1093/bioinformatics/bti722
24. DAWSON JA, YE S, KENDZIORSKI C, R/EBcoexpress: an empirical Bayesian framework for discovering differential co-expression. Bioinformatics 2012; 28: 1939–1940. http://dx.doi.org/10.1093/bioinformatics/bts268
25. FRALEY C, RAFTERY AE, Model-based clustering, discriminant analysis, and density estimation. Journal of the American Statistical Association 2002; 97: 611–631. http://dx.doi.org/10.1198/016214502760047131
26. MOON TK, The expectation-maximization algorithm. Signal processing magazine, IEEE 1996; 13: 47–60. http://dx.doi.org/10.1109/79.543975
27. Wasserman S, Social network analysis: Methods and applications: Cambridge university press, 1994. http://dx.doi.org/10.1017/CBO9780511815478
28. HUANG DW, SHERMAN BT, LEMPICKI RA, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2008; 4: 44–57. http://dx.doi.org/10.1038/nprot.2008.211
29. FORD G, XU Z, GATES A, JIANG J, FORD BD, Expression Analysis Systematic Explorer (EASE) analysis reveals differential gene expression in permanent and transient focal stroke rat models. Brain research 2006; 1071: 226–236. http://dx.doi.org/10.1016/j.brainres.2005.11.090
30. Kreth S, Thon N, Eigenbrod S, Lutz J, Ledderose C, et al., O6-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation. PLoS One 2011; 6: e17156. http://dx.doi.org/10.1371/journal.pone.0017156
31. THON N, EIGENBROD S, Grasbon-Frodl EM, RUITER M, MEHRKENS JH, et al., Novel molecular stereotactic biopsy procedures reveal intratumoral homogeneity of loss of heterozygosity of 1p/19q and TP53 mutations in World Health Organization grade II gliomas. Journal of Neuropathology & Experimental Neurology 2009; 68: 1219–1228. http://dx.doi.org/10.1097/NEN.0b013e3181bee1f1
32. KAPLAN EL, MEIER P, Nonparametric estimation from incomplete observations. Journal of the American statistical association 1958; 53: 457–481. http://dx.doi.org/10.1080/01621459.1958.10501452
33. GILLEN C, WALMSLEY R, PRIOR P, ANDREWS H, ALLAN R, Ulcerative colitis and Crohn‘s disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994; 35: 1590–1592. http://dx.doi.org/10.1136/gut.35.11.1590
34. LOFTUS E, HAREWOOD G, LOFTUS C, TREMAINE W, HARMSEN W, et al., PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 2005; 54: 91–96. http://dx.doi.org/10.1136/gut.2004.046615
35. ASKLING J, DICKMAN PW, KARL N P, BROSTR M O, LAPIDUS A, et al., Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 2001; 120: 1356–1362. http://dx.doi.org/10.1053/gast.2001.24052
36. GARCIA F, KIERBEL A, LAROCCA MC, GRADILONE SA, SPLINTER P, et al., The water channel aquaporin-8 is mainly intracellular in rat hepatocytes, and its plasma membrane insertion is stimulated by cyclic AMP. Journal of Biological Chemistry 2001; 276: 12147–12152. http://dx.doi.org/10.1074/jbc.M009403200
37. Minmin P, Gang S, Ming-Zhou G, Ze-Wu Q, Yun-Sheng Y, Aquaporin 8 expression is reduced and regulated by microRNAs in patients with ulcerative colitis. Chinese medical journal 2013; 126: 1532–1537.
38. FISCHER H, STENLING R, RUBIO C, LINDBLOM A, Differential expression of aquaporin 8 in human colonic epithelial cells and colorectal tumors. BMC physiology 2001; 1: 1. http://dx.doi.org/10.1186/1472-6793-1-1
39. WANG W, LI Q, YANG T, BAI G, LI D, et al., Expression of AQP5 and AQP8 in human colorectal carcinoma and their clinical significance. World J Surg Oncol 2012; 10: 242. http://dx.doi.org/10.1186/1477-7819-10-242
40. LEE HK, HSU AK, SAJDAK J, QIN J, PAVLIDIS P, Coexpression analysis of human genes across many microarray data sets. Genome research 2004; 14: 1085–1094. http://dx.doi.org/10.1101/gr.1910904
41. ZHANG B, HORVATH S, A general framework for weighted gene co-expression network analysis. Statistical applications in genetics and molecular biology 2005; 4. http://dx.doi.org/10.2202/1544-6115.1128
42. MYUNG S-J, RERKO RM, YAN M, PLATZER P, GUDA K, et al., 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis. Proceedings of the National Academy of Sciences 2006; 103: 12098–12102. http://dx.doi.org/10.1073/pnas.0603235103
43. NA H-K, PARK J-M, LEE HG, LEE H-N, MYUNG S-J, et al., 15-Hydroxyprostaglandin dehydrogenase as a novel molecular target for cancer chemoprevention and therapy. Biochemical pharmacology 2011; 82: 1352–1360. http://dx.doi.org/10.1016/j.bcp.2011.08.005
44. YAN M, MYUNG S-J, FINK SP, LAWRENCE E, Lutterbaugh J, et al., 15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors. Proceedings of the National Academy of Sciences 2009; 106: 9409–9413. http://dx.doi.org/10.1073/pnas.0902367106
45. MANN JR, BACKLUND MG, BUCHANAN FG, DAIKOKU T, HOLLA VR, et al., Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression. Cancer research 2006; 66: 6649–6656. http://dx.doi.org/10.1158/0008-5472.CAN-06-1787
46. FRANK B, HOEFT B, HOFFMEISTER M, LINSEISEN J, BREITLING LP, et al., Association of hydroxyprostaglandin dehydrogenase 15-(NAD)(HPGD) variants and colorectal cancer risk. Carcinogenesis 2010bgq231.